Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Jun. 30, 2024
shares
| |
| Trading Arrangements, by Individual | |
| Rule 10b5-1 Arrangement Adopted | false |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Kristie T. Burns | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On May 15, 2024, Kristie T. Burns, our Senior VP Marketing and Clinical Affairs, adopted a pre-arranged trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. This plan provides for the sale of up to 7,444 shares of our common stock in the aggregate and terminates on the earlier of the close of market on August 26, 2025, or the date all shares are sold thereunder. |
| Name | Kristie T. Burns |
| Title | Senior VP Marketing and Clinical Affairs |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | May 15, 2024 |
| Expiration Date | August 26, 2025 |
| Aggregate Available | 7,444 |
| William W. Burke | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On May 28, 2024, William W. Burke, Chairman of our Board of Directors, adopted a pre-arranged trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. This plan provides for the sale of up to 7,013 shares of our common stock in the aggregate and terminates on the earlier of the close of market on December 31, 2025, or the date all shares are sold thereunder. |
| Name | William W. Burke |
| Title | Chairman of our Board of Directors |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | May 28, 2024 |
| Expiration Date | December 31, 2025 |
| Aggregate Available | 7,013 |
| Elaine M. Birkemeyer | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On June 10, 2024, Elaine M. Birkemeyer, Chief Financial Officer, adopted a pre-arranged trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. This plan provides for the sale of up to 84,848 shares of our common stock in the aggregate and terminates on the earlier of the close of market on December 31, 2027, or the date all shares are sold thereunder. |
| Name | Elaine M. Birkemeyer |
| Title | Chief Financial Officer |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | June 10, 2024 |
| Expiration Date | December 31, 2027 |
| Aggregate Available | 84,848 |
| Daniel L. Reuvers | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On June 10, 2024, Daniel L. Reuvers, former Chief Executive Officer and current member of our Board of Directors, adopted a pre-arranged trading plan that is intended to satisfy the affirmative defense of Rule 10b5-1(c) of the Exchange Act. This plan provides for the sale of up to 130,564 shares of our common stock in the aggregate and terminates on the earlier of the close of market on December 31, 2025, or the date all shares are sold thereunder. |
| Name | Daniel L. Reuvers |
| Title | former Chief Executive Officer and current member of our Board of Directors |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | June 10, 2024 |
| Expiration Date | December 31, 2025 |
| Aggregate Available | 130,564 |